In an unusual statement released early Tuesday, the National Institute of Allergy and Infectious Diseases said the independent board that reviews data from multiple Covid-19 vaccine candidates has raised concerns about AstraZeneca's announcement of efficacy data from its vaccine trial.
from CNN.com - RSS Channel - Regions - Europe https://ift.tt/3rgEuHQ
from CNN.com - RSS Channel - Regions - Europe https://ift.tt/3rgEuHQ